BIOXYNE LIMITED — Director's Dealing 2018

Jan 16, 2018

==> picture [596 x 122] intentionally omitted <==

17 January 2018

Change in Director’s Interest Notice – Maxwell Parkin

Attached to this letter is a change in interest notice for Mr Maxwell Parkin (Appendix 3Y) dated 11 December 2017, lodged today 17 January 2018.

This notice was omitted in error from the group of Appendix 3Y’s lodged on 11 December 2017, and Bioxyne Limited provides the following responses for not meeting its ASX listing rule obligation in this regard.

1. The Director concerned provided the necessary information to the Company Secretary within the timeframe required in ASX Listing Rule 3.19A. Due to an administration error the 3Y was not lodged with other appendix 3 Y’s lodged on 11 December 2017.

2. The Company has the required policies and procedures in place to ensure compliance with the disclosure obligations of Listing Rule 3.19A.

3. The Company considers that its current arrangements are adequate to ensure future compliance with ASX listing rule 3.19B.

Yours sincerely,

Guy Robertson Company Secretary

==> picture [457 x 257] intentionally omitted <==

Bioxyne Limited ABN 97 084 464 193, Suite 506, Level 5 50 Clarence Street, Sydney NSW 2000 Telephone +61 2 90787671 E info@bioxyne.com W www.bioxyne.com

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Bioxyne Limited ABN 97 084 464 193

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr Maxwell Parkin
Date of last notice	4 August 2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Jody Parkin (Spouse)
Date of change	11 December 2017
No. of securities held prior to change	Ordinary shares 9,000,000 Unlisted options 2,250,000 exercise price $0.01 expiry 15 December 2017 Unlisted options 1,000,000 exercise price $0.0234 expiry 24 November 2019
Class	Ordinary shares
Number acquired	2,250,000
Number disposed	Nil – exercise of options
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$22,500

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	Ordinary shares 11,250,000 Unlisted options 1,000,000 exercise price $0.0234 expiry 24 November 2019
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Exercise of options at 1 cent per share expiry date 15 December 2017

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 318] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change
----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date N/A was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002